Celiac Disease


Definition: Autoimmune response to dietary gluten and associated proteins (wheat, barley, rye) in individuals with genetic predisposition. (HLA DQ2 & DQ8)

 

Clinical Manifestations


Screening:

High Risk Groups
-Symptomatic patients

-1st and 2nd degree relatives

-Type 1 Diabetes

-Down syndrome

-Turner Syndrome

-Williams syndrome

-IgA deficiency

-Autoimmune thyroid disease


 

Testing:


1.       TTG IgA and Total IgA

a.       Positive with symptoms -- > endoscopy

b.       >10x uln (Europe) check EMA, if positive Dx and Tx with GFD

c.       Low IgA (<5) obtain TTG-IgG and DGP-IgG, if positive -- > endoscopy

d.       Negative, consider HLA / genetics and/or repeat testing

2.       Genetics

a.       95% HLA DR3-DQ2

b.       5% HLA DR4-DQ8

c.       If patient doesn’t have one of these genes, celiac disease effectively ruled out

3.       Endoscopy

a.       Obtain Biopsies from the Duodenal bulb (at least 2) and 2nd portion of duodenum (at least 4)

b.       4wks on a gluten containing diet usually adequate to observe mucosal changes

                                                               i.      >10g gluten a day

c.       Patients on steroids or other immunosuppressives may have false negative bx results

d.       Marsh Criteria for grading Biopsies






Treatment


Lifelong adherence to gluten free diet (GFD)
Refer to nutrition
Patient education


Follow up

TTG-IgA q6mo until normal, then annually to confirm adherence to GFD


Outcomes:


Symptoms can resolve within a few weeks on gluten free diet

Mucosal healing and remission may take 6-12mo

Obtain TTG-IgA q6mo until normal, then check annually to assess compliance

Increase in all cause mortality with celiac disease due to GI malignancies (decreased risk on gluten free diet)






References:

Hill ID, Fasano A, Guandalini S, et al. NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten-related Disorders. J Pediatr Gastroenterol Nutr 2016; 63:156.

https://naspghan.org/files/documents/pdfs/position-papers/NASPGHAN_Clinical_Report_on_the_Diagnosis_and.28.pdf

NASPGHAN fellows review 2nd Ed.